VICKEY HALL: Open Payments
NPI 1063746345 · IUKA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 29 payments from 12 companies in 2025. Trend: 2023 $845 · 2024 $459 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $113 |
| Lilly USA, LLC | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $60 |
| AstraZeneca Pharmaceuticals LP | 4 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Novo Nordisk Inc | 3 | $48 |
| Abbott Laboratories | 2 | $43 |
| Lundbeck LLC | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
Products named: REXULTI, ELIQUIS, MOUNJARO, Auvelity, NURTEC ODT, BREZTRI, FREESTYLE LIBRE 3, Rybelsus.
Industry payments across MS — which companies pay providers there.
